HIVR4P 2021 MHRP & Collaborators Schedule:
Bold = MHRP; Italicized = Collaborator
Pre-conference Satellites:
Thursday January 28:
7:45-8:45am (EST): Matt Johnston: Co-enrollment identification “Engaging Lake Victoria Fishing Communities in HIV Prevention Research: Lessons from Uganda, Kenya and Tanzania”
Wednesday February 3:
1:45-3:15pm (EST): Trevor Crowell: Engagement of African Men and Transgender Women Who Have Sex with Men in HIV Research
Oral Presentations:
Wednesday January 27
12:30-1:30pm (EST): Carolyn Williamson: "Analysis of genetic diversity and VRC01 pressure on HIV-1 breakthrough viruses from the AMP trial (HVTN 703/HPTN 081 and HVTN 704/085)
Thursday February 4
10:00-11:00am (EST): Col Julie Ake (Session Co-Chair) - In vivo modulation of immune response to vaccination
11:15-12:15pm (EST): Sandhya Vasan "An ambitious and advancing pipeline: T-cell and non-neutralizing antibody-based vaccine strategies: “Progress with delayed boosting vaccination”
12:30-1:30pm (EST): Alexandra Schuetz: Dynamics of Mucosal Immune Responses Elicited by Systemic Prime/Boost Vaccination
On-Demand Posters:
- Thembi Mdluli: “Impact of pre-ART variables on time to viral rebound after treatment interruption in acutely treated HIV-1 infected participants” (poster)
- Nicole Dear: “Factors Associated with Transactional Sex in the African Cohort Study” (poster)
- David Chang: Viral Suppression and CD4 counts with transition to TDF/2TC/DTG (TLD)
- Allahna Esber: Partner type, serodiscordance status, and dual contraceptive method use in the African Cohort Study
- Samantha Townsley: "Founder Env-specific IgM B cell responses during acute HIV-1 infection associate with the development of broadly neutralizing antibodies" (poster)
- Alexandra Schuetz: Impact of Gender Affirmation Surgery and Exogenous Hormones on Mucosal Immune Responses and Risk of HIV Transmission in Transgender Women
- Nkechinyere Harrison: “Effect of multi-month ARV dispensing on HIV clinic attendance at 68 Nigerian Army Reference Hospital Yaba, Lagos” (late breaker poster)
- Vincent Muturi-Kioi "Recommendations and considerations for developing a biometric system to prevent co-enrollment in HIV and infectious disease clinical trials"
- Siriwat Akapirat: Vaccination with Ad26.ZEBOV, MVA-BN-Filo or MVA-BN-Filo, Ad26.ZEBOV induced predominantly IgG binding to Ebola glycoprotein in cervico-vaginal mucus in HIV-infected and uninfected participants.